At 13.6% of CAGR Epigenetics Market is reaching $2,611.57 Million by 2025

1. Epigenetics Market Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published Epigenetics Market to 2025 - Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments & Consumables and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation and Others), Application (Oncology, Cardiovascular Diseases and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) and Geography E-Mail : sales@theinsightpartners.com

2. Epigenetics Market Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published Introduction: The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes. The report would be of an interest to various stakeholders operating in the epigenetics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms. The objective of the study is to describe, define, and forecast the epigenetics market by technology, product, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market. The report analyzes factors affecting epigenetics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key epigenetics manufacturing companies along with their SWOT analysis and market strategies. E-Mail : sales@theinsightpartners.com

3. Epigenetics Market Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published The global Epigenetics Marketis expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 Mn in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years. This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP).  In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market. E-Mail : sales@theinsightpartners.com

4. Epigenetics Market Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published Epigenetics market is segmented by technology, product, application and end user. Global epigenetics market, based on product the segment is segmented as reagents, kits, enzymes, instruments and consumables and bioinformatics tools. Global epigenetics market, based on the technology was segmented into histone modification, DNA methylation and other technologies. The epigenetics market, based on application was segmented into metabolic diseases, oncology, cardiovascular diseases and other applications. The epigenetics market, based on end user was segmented into contract research organizations, pharmaceutical & biotechnology companies. In recent years, the demand for cutting edge technology in order to gain high speed results and accuracy is increasing. Technological development has enabled advances in sequencing technology leading to a sharp increase in the cost of sequencing equipment. Companies such as Illumina and PacBio offer instruments with high cost. For instance, IlluminaMiSeq cost for US$ 128,000 and PacBio RS cost for US$ 695,000. Thus, the high cost of next generation sequencers is hindering the growth of the market for in the future. E-Mail : sales@theinsightpartners.com

5. Epigenetics Market Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published • The List of Companies • 1. Merck KGaA2. Thermo Fisher Scientific, Inc.3. Abcamplc4. Agilent Technologies5. Active Motif6. QIAGEN7. Bio-Rad Laboratories, Inc.8. PerkinElmer Inc.9. New England Biolabs (NEB)10. Illumina, Inc. Get Sample PDF Copy E-Mail : sales@theinsightpartners.com